Inter-American Development Bank
facebook
twitter
youtube
linkedin
instagram
Abierto al públicoBeyond BordersCaribbean Development TrendsCiudades SosteniblesEnergía para el FuturoEnfoque EducaciónFactor TrabajoGente SaludableGestión fiscalGobernarteIdeas MatterIdeas que CuentanIdeaçãoImpactoIndustrias CreativasLa Maleta AbiertaMoviliblogMás Allá de las FronterasNegocios SosteniblesPrimeros PasosPuntos sobre la iSeguridad CiudadanaSostenibilidadVolvamos a la fuente¿Y si hablamos de igualdad?Home
Citizen Security and Justice Creative Industries Development Effectiveness Early Childhood Development Education Energy Envirnment. Climate Change and Safeguards Fiscal policy and management Gender and Diversity Health Labor and pensions Open Knowledge Public management Science, Technology and Innovation  Trade and Regional Integration Urban Development and Housing Water and Sanitation
  • Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

Gente Saludable

IDB

  • HOME
  • CATEGORIES
    • Aging and Dependency
    • Courses and Seminars
    • Digital Transformation
    • Public health and nutrition
    • Healthy Lifestyle
    • Health services
    • Health Spending and Financing
    • Women’s and Children’s Health
  • authors
  • English
    • Spanish
    • Portuguese

A one-stop shop for our webinars on COVID-19

April 5, 2021 por Marcella Distrutti Leave a Comment


About a year ago, in March 2020, people worldwide were having their last workday in the office. Although life has slowly begun to return to some level of normalcy in some places, at least for now, in many others – perhaps most –, people with desk jobs are still working from home. 

At the IDB, in March 2020, we began organizing a series of webinars about COVID-19, focusing on non-pharmacological interventions to slow the spread of the pandemic and countries’ experiences tackling the health emergency, to contribute towards the generation and dissemination of information and knowledge about the pandemic. 

One year later, in March 2021, we are beginning a new series of webinars about COVID-19, but this time focused on vaccines. On the first webinar of this series, we will be discussing the main bottlenecks to increase COVID-19 vaccine production and what could be done to increase manufacturing capacity in the short and medium terms.

In an upcoming event, we will be discussing the cases of Chile and Israel, and the American state of West Virginia, and how they manage to have vaccination programs that are among the fastest in the world, having inoculated significant shares of the population.

It is a remarkable achievement for humanity that we are now discussing how to expand vaccine production. Through human ingenuity, innovation, and the hard work of many, from scientists and pharmacologists to governments and organizations, the world has developed and started producing several vaccines that have been proven to be safe and effective. A process that usually takes years has been reduced to a few months. 

Our challenge now is to scale up production and ensure that no one is left behind. In other words, that there is equity in the distribution and use of these vaccines for the sake of humanity itself, as the more the virus spreads, the more the chances that new variants, potentially posing new threats, could emerge. 

In this webinar, three outstanding experts with extensive academic and professional experience in the pharmaceutical industry will discuss some of the main challenges we face to expand production, including issues related to infrastructure, the time needed to expand and/or repurpose plants, and the compliance with good manufacturing practices and other regulatory requirements; highly specialized equipment and the time needed to procure them; the availability of single source inputs, whose use in production lines has increased; the availability of raw materials, such as lipid molecules used in mRNA vaccines; the availability of auxiliary capacity, such as glass materials; and technology transfer – how easy, or how difficult, it is to transfer technology and know-how to other manufacturers around the world, among many others topics. 

They will also discuss which vaccine platforms have the strongest potential for scaling up in low- and middle-income countries and some of the policy options that could be put in place to contribute to scale-up the industrial capacity for vaccine manufacturing. For instance, are there potential incentives to create a more enabling environment for production? 

Obviously, there is so much that can be discussed in a one-hour session. Nevertheless, we hope that everyone who joins us will learn a little about some of these challenging issues. Challenges that, surely, are not over. The new variants do pose an array of new questions to humankind that will have to be answered. This, indeed, will be the topic of one of the other webinars in our series. If there is one thing that we are all learning together in this pandemic, is that humanity is resourceful and can do a lot to face common threats.  

Check out our past webinars on the fight against COVID-19: 

  • What can Latin American and the Caribbean Countries learn from the Korean experience with COVID-19  
  • COVID-19: What works to Flatten the Curve 
  • German experience in managing COVID-19 
  • China experience in managing COVID-19 
  • How can Latin America and the Caribbean prepare to produce tests and medical devices to respond to COVID-19? 
  • Israel experience in managing COVID-19 
  • COVID-19 forecasts for Latin American Countries, using the IHME epidemiological model 
  • How to prioritize health interventions in times of a pandemic? Scarce resources and infinite demands 

Filed Under: Courses and Seminars, English Tagged With: Banco Interamericano de Desarrollo, BID, coronavirus, covid-19, covid-19 vaccine, health technologies, healthcare, healthcare system, IDB, interamerican development bank, políticas públicas, Salud

Marcella Distrutti

Marcella Distrutti se desempeña desde 2015 como Especialista en Salud en la División de Protección Social y Salud del Banco Interamericano de Desarrollo (BID), al cual se incorporó en 2013 como Young Professional. Antes de unirse al BID, Marcella trabajó en el Ministerio de Salud de Brasil, apoyando el diseño y la implementación de políticas de salud sexual y reproductiva. También trabajó como consultora para organizaciones como el Banco Mundial. En 2018, junto a otras especialistas en el área de salud, fue coautora del libro “La priorización en Salud paso a paso: Cómo articulan sus procesos México, Brasil y Colombia”. Marcella posee un Máster en Financiamiento, Planificación y Políticas de Salud de la Escuela de Higiene y Medicina Tropical de Londres (LSHTM) y la Escuela de Economía y Ciencias Políticas de Londres (LSE) y un Máster en Desarrollo Internacional y Economía de la Escuela de Estudios Internacionales Avanzados (SAIS) de la Universidad Johns Hopkins.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Follow Us

Subscribe

Search

Health

Latin American and Caribbean countries face multiple challenges to provide quality healthcare for their citizens. In this blog, IDB Specialists and international experts discuss current health issues and hope to build a dynamic dialogue through your comments.

Similar Posts

  • Three Impacts of Digital Health on Healthcare
  • Trapped in a Hospital for Too Long? Intermediate Care Provides Escape
  • Finding Signals in the Data Noise

Footer

Banco Interamericano de Desarrollo
facebook
twitter
youtube
youtube
youtube

Blog posts written by Bank employees:

Copyright © Inter-American Development Bank ("IDB"). This work is licensed under a Creative Commons IGO 3.0 Attribution-NonCommercial-NoDerivatives. (CC-IGO 3.0 BY-NC-ND) license and may be reproduced with attribution to the IDB and for any non-commercial purpose. No derivative work is allowed. Any dispute related to the use of the works of the IDB that cannot be settled amicably shall be submitted to arbitration pursuant to the UNCITRAL rules. The use of the IDB's name for any purpose other than for attribution, and the use of IDB's logo shall be subject to a separate written license agreement between the IDB and the user and is not authorized as part of this CC- IGO license. Note that link provided above includes additional terms and conditions of the license.


For blogs written by external parties:

For questions concerning copyright for authors that are not IADB employees please complete the contact form for this blog.

The opinions expressed in this blog are those of the authors and do not necessarily reflect the views of the IDB, its Board of Directors, or the countries they represent.

Attribution: in addition to giving attribution to the respective author and copyright owner, as appropriate, we would appreciate if you could include a link that remits back the IDB Blogs website.



Privacy Policy

Derechos de autor © 2023 · Magazine Pro en Genesis Framework · WordPress · Log in

Banco Interamericano de Desarrollo

Aviso Legal

Las opiniones expresadas en estos blogs son las de los autores y no necesariamente reflejan las opiniones del Banco Interamericano de Desarrollo, sus directivas, la Asamblea de Gobernadores o sus países miembros.

facebook
twitter
youtube
This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser.
To learn more about cookies, click here
X
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT